PRFX Stock Summary and Trading Ideas (PRF Technologies Ltd. - | NASDAQ:PRFX)

PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasize reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the company's lead product, is based on the local anesthetic ropivacaine and targets the postoperative pain relief market. The company has two operating segments composed of the Clinical Development segment, which facilitates the development of potential new drug compounds, and the Solar segment, which comprises the design and development of the company's intellectual property and the sale related service offerings.

PRF Technologies Ltd. - trades on the NASDAQ stock market under the symbol PRFX.

As of April 24, 2026, PRFX stock price declined to $2.28 with 14,820 million shares trading.

PRFX has a beta of 2.71, meaning it tends to be more sensitive to market movements. PRFX has a correlation of 0.16 to the broad based SPY ETF.

PRFX has a market cap of $1.93 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, PRFX traded as high as $3,169.20 and as low as $1.80.

PRFX has underperformed the market in the last year with a price return of -80.3% while the SPY ETF gained +31.9%. PRFX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -41.8% and -14.0%, respectively, while the SPY returned +3.8% and +5.1%, respectively.

PRFX support price is $2.21 and resistance is $2.61 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PRFX shares will trade within this expected range on the day.